Business Context and Reporting Period
This Form 8-K reports on the annual meeting of stockholders held by Gossamer Bio, Inc. on June 17, 2020. The filing details the results of votes submitted to security holders regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing reports the following corporate governance outcomes:
- Director Elections: Two Class II directors were re-elected for a three-year term expiring at the 2023 annual meeting:
- Faheem Hasnain: 50,254,867 votes For; 4,635,952 votes Withheld; 5,140,922 Broker Non-Votes.
- Joshua Bilenker, M.D.: 50,525,492 votes For; 4,365,327 votes Withheld; 5,140,922 Broker Non-Votes.
- Auditor Ratification: The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020, was ratified.
- Votes For: 59,938,604
- Votes Against: 67,673
- Abstentions: 25,464
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Investor Verification Checklist
- Verify the total number of shares entitled to vote to contextualize the "For" and "Withheld" vote counts.
- Confirm the term expiration dates for the newly elected Class II directors (2023).
- Review the full proxy statement for detailed biographies of the elected directors and the rationale for the auditor selection.